American researchers believe that 97% of people over the age of 66 should regularly take statins to reduce their risk of heart disease. But there is still no consensus within the medical community on the benefits of the drugs. EURACTIV France reports.
A new generation of anticoagulants have been blamed for the deaths of patients in France. Studies from two leading French health agencies conclude that they do not pose a serious risk, but doubts remain. EURACTIV France reports.
The Chief Medical Officer (CMO) for England, Professor Dame Sally Davies, has pointed to the danger of bacteria's growing resistance to antibiotics, saying an EU funded medical initiative may be the solution to the problem.
The OECD is urging its member governments to harmonise their clinical trial approval processes, citing a decline in the pharmaceutical sector in the EU, where the number of applications for clinical trials fell 25% between 2007 and 2011.
Voting on a draft law Wednesday (6 February), the European Parliament said patients should have quicker access to cheaper generic medicines. The draft rules will require national authorities to meet new deadlines and transparency standards on pricing and reimbursement.
More transparency on the pricing and reimbursement of medicines should be the rule for the future to improve patient's access to affordable treatments, MEPs said after backing draft legislation in the environment and public health committee.
Health specialists urged the European Commission to include provisions to its revised proposal for the controversial Information to Patients directive, expected for early October, so that patients are fully instructed on how to take medicine properly.
Patients should get better information on prescription drugs following a vote in the European Parliament yesterday (24 November) that aims to better educate consumers and protect them from hidden advertising.
The system for medical innovation is broken. The number of people struggling to obtain or afford essential medicines is rising at a dangerous pace. There must be a radical overhaul, said experts at a European Parliament hearing on Thursday (18 November).
Controversial plans to allow pharmaceutical companies to publish medicines information in newspapers have been scrapped by MEPs. The original proposal from the European Commission had been branded "advertising in disguise" by consumer groups, who welcomed the Parliament's U-turn.
University researchers have criticised the €2 billion public-private Innovative Medicines Initiative (IMI), claiming their participation is at risk unless major changes are made to financial and intellectual property arrangements.
A Russia-based online pharmacy has been using the logo of a high-profile European pharmacists' lobby group to claim their products are endorsed by the Brussels-based organisation, EURACTIV has learned.
New technology designed to combat counterfeit drugs has been successfully trialled by pharmacists in Sweden, as a new EU directive on tackling fake medicines makes its way through the European Parliament.
The top official at the EU's competition office has told the European Parliament that some medicine makers effectively represent an obstacle to making savings in the health sector. However, he acknowledged that research-based pharma companies must be incentivised to produce new medicines.
Europe's pharmaceutical companies will allow an independent authority to vet information provided to patients under a controversial proposal that would allow industry to communicate directly to consumers.
European medicine authorities are growing increasingly alarmed by the number of bogus swine flu remedies being sold over the Internet. The news comes as MEPs gear up to debate new rules covering counterfeit medicines.
The EU executive's decision not to legislate against online pharmacies is a major flaw in its proposal to fight counterfeit medicines, according to leading politicians responsible for pushing the new law through the European Parliament.